Suman Datta, Ms, Mba Email & Phone Number

California, United States

Campbell, Ca, Us

Velox is an investor-backed company that partners with innovation-driven companies in their commercialization and product development journeys. We provide professional services supercharged through custom RAG models and large language models, including Product Development Research, Market Access and Reimbursement, and Marketing Research.

Campbell, California, Us

Legacy Health Capital acquires and grows specialized services businesses that serve Life Sciences companies throughout their product development and commercialization lifecycle.

Irvine, Ca, Us

Commercial strategy, Payer (market access and reimbursement), Business development

Milpitas, California, Us

Developed Bigfoot's product commercialization strategy and execution plans as the commercial launch lead for Bigfoot Unity - a Digital Smart Cap that makes Insulin Dependent Diabetes Management seamless for people with T1 and T2 Diabetes.With an innovative digital health bundled (medical devices, software and services) subscription based business model, I focused on Coverage, Coding and Reimbursement by developing strategy and executing the plan to gain traction with commercial payers and employer groups.Currently, building the commercial business infrastructure for Sales Operations in SFDC. Driving initiatives in Market Access and Reimbursement including Payer Marketing and Sales, Value-Based Contracting, Pricing, HCP (Physician) and Consumer (Patient) Marketing.

Milpitas, California, Us

Executed business development deals and subsequent partnership and alliance management of development and commercial partners. Brought in to initially develop a strong Business Development and Partnerships function for executing company strategy. Drove forward key business deals and managed the resulting on-going partnerships effectively. Promptly took a consultative approach to develop a process and then implemented it by leading cross-functionally to drive towards a common goal of successful-partnerships management. Used relationship building, influencing, and negotiating skills both internally/externally to develop, align trade-offs within functions, and execute, three key deals with bio-pharma and medical device partners to build investor confidence, secure critical parts for the system being built and establish potential future channels to market. A winning partnerships-management process is now being used for partnerships at all stages (new and existing).

Forchheim, De

Created new product lines and businesses and grew Siemens' healthcare business through new product incubation ventures, Partnerships, and Joint-Venture (JV).- Developed 2 new products and services through organic incubation projects for commercialization- Identified 1 partnership to further Siemens' growth in new market segments- Conducted due diligence on potential M&A, JV, and partnerships within value-based healthcare enabling businesses- Made and guided key decisions on strategic areas of focus for Siemens Healthineers and strategic investments in alignment with Siemens Healthineers Leadership- Created opportunities and ensuring successful relationships between startups and SiemensThere were many engagements during this time. For example, in one case, Siemens needed to assess the viability of digital service in ultrasound space to invest in new partner venture: The internal team was struggling to articulate investment value to execs., so developed a plan. Led execution development by engaging with internal and external experts and consultants. Articulated the value proposition and inherent risks of new market entry with a business model.By month 5, executives understood the business-model value and invested in the partner to create a new ultra-sound-on-demand business ($100M+/Yr.) with Siemens’ resources and expertise.

Minneapolis, Mn, Us

As a founding member of the new Type 2 Diabetes group, led a cross-functional team on creation of a global strategic plan, product roadmap and budget resulting in entry into $8B glucose monitoring market and doubling of revenues within 1 year of launch.Worked with R&D on product requirements to incorporate customer research into product development.Developed marketing plans, concept templates, naming and branding for existing and new products and services.Developed market development pilots with Diabetes clinics to expand glucose monitoring market. Was instrumental in developing product portfolio focus and offerings. Conducted market research with patients and physicians to help uncover new market opportunities. Trained in Voice of Customer methodologies. Created a robust T2 diabetes market model for competitive landscape assessment, revenue forecasting and helped leadership articulate value proposition. Developed detailed financial models and marketing dashboards (tactical) that helped drive key strategic decisions in pricing, partner negotiations and investments into products, services and marketing campaigns. Served as a central point of contact for strategy, market research, and analytics for regional marketing teams leading to dissemination of tools, ideas, and best practices.As part of the business development efforts, led due-diligence on startups (R&D, commercial, financial aspects) for investment, partnerships, and acquisition. Led fundraising activities as part of a cross-functional team and helped do pitch decks to fund product development through external funding sources (venture capital and foreign government agencies) resulting in the signing of MoU with one funding partner.

Thousand Oaks, Ca, Us

As a Strategy manager, developed strategic options for workforce optimization and site rationalization through working with senior executives and external consultants. As a Finance manager, led the development and execution of hedging strategy through derivatives trading to manage $7B company-wide interest rate and foreign-exchange risk portfolio that reduced EPS risk. Also managed the treasury P&L budget. Improved trading efficiency in the group 3 fold as a result of improved trading models and other operational efficiency gains.Led diligence of competitor strategies and provided recommendations for Amgen’s India entry strategy. Developed a tactical asset allocation model (multi-variable regression-based) for $20 billion investment portfolio to manage investment income for Amgen.

Founded an ethical fashion business aimed at reducing the inequities in the supply chain of retail messenger bags. Entrepreneurial efforts including making investor presentations, helping devise company strategy, setup of partnerships with charities and manufacturers, negotiating contracts with a manufacturer, recruiting team members and interns to work on business and managing company operations.In the first 9 months of starting production, sold over 300 + bags with a dozen different SKUs.

Paris, Fr

Led M&A due diligence to identify major European pharmaceutical company’s potential $50 - $100M acquisition targets for North American market entry resulting in acquisition by client. Analyzed competitive strategy landscape for Pharma and Retail sector which helped secure major client accounts. Developed Access and Reimbursement vendor strategy for large biotech with a cross-functional team. Supported business operations project at large biotech while implementing business process integration strategy. Authored white papers on trends in U.S. healthcare, including Healthcare Reform, Comparative Effectiveness Research and Electronic Health Records that aided in generating new projects from clients worth over $20M.

Cambridge, Massachusetts, Us

Executed, as part of a multidisciplinary AI/ML and Biology team, 2 key drug discovery programs.Evaluated therapeutic projects to be selected for further development.Contributed to solving organizational issues of a fast-growing startup company through task forces setup to identify and solve problems.

Philadelphia, Pa, Us

Executed electrophysiology experiments to understand calcium ion channel gating in insect cells.Publication: Rapid ligand-regulated gating kinetics of single inositol 1,4,5-trisphosphate receptor Ca2+ release channelsEMBO reports 8, 11, 1044–1051 (2007)

Philadelphia, Pennsylvania, Us

Implemented a scalable fuzzy (AI/ML) model of biomolecular network dynamics.Publication: Accelerated search for biomolecular network models to interpret high-throughput experimental dataBMC Bioinformatics 2007, 8:258.Researched projects to study HTLV-1 and incorporated various molecular biology techniques including gels, PCRs, real time PCR, protein quantitation, FACS, DNA/RNA extraction/preparation and Microarrays in researchPublication: Use of human antigen presenting cell gene array profiling to examine the effect of human T cell leukemia virus type 1 Tax on primary human dendritic cells. Journal of NeuroVirology, 12:47-51, 2006

Mba, Finance, Entrepreneurship

Leading Professional Services Firms

Design Thinking

Master Of Business Administration (Mba), Strategy And Innovation

Ms, Biomedical Engineering

B.E., Biomedical Engineering

High School Certificate Exam